Balance Sheet Data
Aurinia Pharmaceuticals Inc. (AUPH)
$9.29
+0.55 (+6.29%)
Year A/P | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Actual | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected |
| Total Cash | 125.86 | 306.02 | 398.33 | 466.08 | 389.39 | 1,363,898.53 | 55,285,450.92 | 2,240,988,611.24 | 90,838,183,865.90 | 3,682,114,048,527.85 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Cash (%) | ||||||||||
| Account Receivables | 0.22 | 0.37 | 1.02 | 15.41 | 13.48 | 2,265.31 | 91,824.12 | 3,722,078.93 | 150,873,988.70 | 6,115,657,641.89 |
| Account Receivables (%) | ||||||||||
| Inventories | - | - | 13.93 | 19.33 | 24.75 | 1,605.11 | 65,062.85 | 2,637,314.40 | 106,903,198.70 | 4,333,307,349.37 |
| Inventories (%) | ||||||||||
| Accounts Payable | 2.95 | 4.15 | 2.63 | 3.88 | 3.09 | 21,290.47 | 863,006.56 | 34,981,859.60 | 1,417,985,159.82 | 57,477,845,278.13 |
| Accounts Payable (%) | ||||||||||
| Capital Expenditure | -0.07 | -0.10 | -7.34 | -1.50 | -0.29 | -728.70 | -29,537.73 | -1,197,307.95 | -48,532,723.17 | -1,967,267,664.44 |
| Capital Expenditure (%) |
To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows)
and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.